✦ LIBER ✦

PMH15 COST-EFFECTIVENESS ANALYSIS OF LONG-ACTING RISPERIDONE (LA-RIS) VS HALOPERIDOL DECANOATE AND ORAL OLANZAPINE IN THE TREATMENT OF SCHIZOPHRENIA IN ITALY

✍ Scribed by A D'Ausilio; F Amaddeo; C Mencacci; C Munizza; H Miadi-Fargier; P Berto

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH42 COST-EFFECTIVENESS ANALYSIS OF OLA

✍ SM Carroll; N Jemiai; B Suter; P O'Donohoe; U Skjoldborg; J Moller; OK Kleivenes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PMH3 A COST-EFFECTIVENESS COMPARISON OF

✍ S Beard; M Lothgren; L Giudi; F Ramacciotti; M Nardini; D Berardi 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PMH15 COST-EFFECTIVENESS OF AMISULPRID C

✍ E Kowalik; M Jakubczyk; J Lis; M Niewada 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PMH23 A Cost-Effectiveness Analysis of t

✍ T.R. Einarson; H. Pudas; R. Zilbershtein; R. Jensen; A.T. Nielsen; C. Piwko; M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Decision analysis model evaluating the c

✍ Mark Bounthavong; Mark P. Okamoto 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

PMH26 USING THE NET-BENEFIT REGRESSION A

✍ A De Ridder; D De Graeve 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB